Extending the duration of first-line chemotherapy in metastatic breast cancer: a perspective review. (Q35205290)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

review article

1 reference

title

Extending the duration of first-line chemotherapy in metastatic breast cancer: a perspective review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

metastatic breast cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Mauro D'amico

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Davide Corradengo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic advances in medical oncology

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

229-232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer

13 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Duration of chemotherapy for metastatic breast cancer: a systematic review and meta-analysis of randomized clinical trials.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Maintenance treatment with pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Maintenance hormone therapy with letrozole after first-line chemotherapy for advanced breast cancer

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients. clinical outcomes and oncologists' preferences

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3169930

Epirubicin-based chemotherapy in metastatic breast cancer patients: role of dose-intensity and duration of treatment

26 September 2018

1 reference

12 December 2020

A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast

1 reference

12 December 2020

Chemotherapy for metastatic breast cancer--when is enough enough?

1 reference

12 December 2020

Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months

1 reference

12 December 2020

Identifiers

DOI

10.1177/1758834011413423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

release_35xvfk3iovbpng4dvehhzziwje

13 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/35xvfk3iovbpng4dvehhzziwje

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21957429%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

PubMed publication ID

21957429

1 reference